Forget Vertex Pharmaceuticals -- CRISPR Therapeutics is a better buy right now.
3d
Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That.
Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...
Scientists have long sought to understand why some plants are fragrant powerhouses while others remain subtle. Now, a ...
With a shared purpose, we can realize the true promise of CRISPR and improve healthcare, providing hope to more patients with ultra-rare genetic disorders.
Faced with a life-threatening metabolic disease, KJ’s doctors at Children’s Hospital of Philadelphia sprinted to create a ...
Scientists are testing an entirely new way to fight heart disease: whether gene editing might offer a one-time fix for high ...
The Canadian government's recent approval of the first gene-edited animal to enter the food system has reignited debates over ...
The idea of self-amplifying gene editing is to get cells to pass on packages of CRISPR machinery to their neighbours, boosting the effect ...
UCLA researchers have developed a lipid nanoparticle-based gene-editing approach capable of inserting an entire healthy gene into human airway cells, restoring key biological function in a laboratory ...
In this webinar, researchers discuss using and improving next-generation gene editing approaches for targeted, accurate, and ...
Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results